Operators can test and evaluate a NeuCool™ system rack as part of this staged journey from technology approval to scale Accelsius™ to provide dedicated attention from thermal subject matter experts ...
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors ...
(RTTNews) - eFFECTOR Therapeutics, Inc. (EFTR) announced Thursday topline results from the primary analysis of the randomized Phase 2 KICKSTART trial which tested tomivosertib or placebo, each ...
The mid-stage studies will assess the safety, acceptability, and pharmacokinetics of lenacapavir injection every six months. FDA has already approved Lenacapavir for HIV treatment, in combination with ...
NEW YORK--(BUSINESS WIRE)--Braze (Nasdaq: BRZE), the leading customer engagement platform that empowers brands to Be Absolutely Engaging™, today announced two new launches to help brands elevate their ...
This project explores the fascinating possibilities of time travel, combining scientific theories like Einstein's relativity and the concept of wormholes with engaging narratives that challenge our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback